BioQuest Corp.
BQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$746.31K
Close$
$-0.01
104% downside
Current Fair Value
104% downsideOvervalued by 104% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $746,308.00 |
|---|---|
| Enterprise Value | $1.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 9.57 |
| Outstanding Shares | 2,985,230 |
Return
| Return on Equity | 59.30% |
|---|---|
| Return on Assets | -17515.39% |
| Return on Invested Capital | 52.88% |
Valuation & Multiples
| P/E Ratio | -8.74 |
|---|---|
| PEG | 9.51 |
| Price to Sales | - |
| Price to Book Ratio | -0.25 |
| Enterprise Value to Revenue | 6.13 |
| Enterprise Value to EBIT | -1.9 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | -0.35 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioQuest Corp.
4 employees
CEO: Trent T. Daniel BioQuest Corp. has transitioned from its origins as a biotechnology company into the conversational artificial intelligence (AI) and automation sector. Through its acquisition of BotMakers, Inc., the company develops and offers AI-powere...